Cigna Insider Buying is a rarity. Only one corporate insider had bought shares of the giant health insurer on the open market since 2003. That changed dramatically on Monday, as Cigna (CI) CEO David Cordani disclosed the purchase of 32,509 shares of his company's stock at $155.17....
"Insiders are selling stock like it's 2007." That's a headline from August 27, 2019. Sounds ominous. One might have been inclined to think: The smart guys are dumping stock, guess I should too. Well that would have been a big mistake. Since that headline was posted, the...
After regular market hours on Wednesday, the Head of Alternative Investments for B. Riley Capital filed Form 4s disclosing personal purchases of Health Insurance Innovations (HIIQ) shares in addition to purchases for the fund he manages. Also after market hours, Paul Gabos, a HIIQ...
When the equities in your portfolio plummet, you may find yourself asking: What are these stocks really worth? They’ve fallen ten or twenty percent – what’s to keep them from declining even further? Well here’s one thing that can anchor a portfolio: Sizeable dividend payments.
On Friday, Engaged Capital LLC, a big holder of Hain Celestial Group, announced it bought $19 million more of HAIN, even though the stock had popped 10% over the previous couple days. Often, corporate insiders buy into share weakness...
Edgewater Technology (NASDAQ:EDGW) is a Massachusetts-based business and IT consulting firm with a market cap of $75 million and annual revenue of about $100 million. According to the company’s website, one security analyst follows the company. It’s the kind of stock that, as an old colleague of mine liked to say, “trades by appointment.” Average trading volume of EDGW is about 20,000 shares per day – or about $100K in average daily dollar volume. That’s too small for the typical hedge fund to mess with.
In May of 2015, Nelson Obus’s lawyer opened his client’s trial by saying that either the hedge fund manager is an honest man or "the lamest insider trader in history." Twelve years after he was first charged by the SEC for insider trading, Obus, the manager of New York-based hedge fund Wynnefield Capital Inc., was found not guilty by a jury. Fast forward to January 14, 2019 and Obus just submitted an insider filing to his nemesis the SEC,  disclosing that his fund purchased 20,000 shares of Landec Corp. (LNDC) at $11.33. It’s a trade that investors may want to note – not because of any alleged impropriety, but because the stock being bought may be an attractive opportunity.
It’s always good to see insiders buy a stock into price weakness -- it suggests the selloff is a buying opportunity, rather than a sign of more weakness to come. In the case of Apple Hospitality (NYSE: APLE), insider buying indicates executives who know the REIT best believe it’s oversold.
Nothing like putting a million bucks where your mouth is. After a presentation yesterday at the JPMorgan healthcare conference yesterday, an analyst bad-mouthed medical device giant Medtronic Plc (MDT) and cut price targets. As the stock tumbled over 6%, Medtronic CEO Omar Ishrak went on television to defend his company and debunk critics. Then today he bought $1 million dollars of MDT on the open market.
Stock market prognosticators are getting bearish. “We’re now in a bear market, get ready for lower prices…” a growing chorus of pessimistic “experts” are saying. “Watch out for the Death Cross!” Yikes. Of course, this great advice comes after the market has already tanked 10%. Where was this helpful advice in Sept. before things went south in a hurry?